Across TCGA patient cohorts, SUPT20HL2 mutation is significantly associated with the RNA expression of many other genes, with 967 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible SUPT20HL2-associated genes across cancer lineages are RN7SL66P, URGCP-MRPS24, and CXCL13. Each is linked with SUPT20HL2 in more than 2 cancer types. Because this analysis shows association rather than direction, both SUPT20HL2-to-partner and partner-to-SUPT20HL2 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SUPT20HL2→partner) and Y-score (partner→SUPT20HL2) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CESC	RN7SL66P →	+0.158	+5.010	<.001	.009	3	3
UCEC	URGCP-MRPS24 →	+0.156	+1.747	<.001	.002	3	2
UCEC	CXCL13 →	+1.870	+2.700	<.001	<.001	3	2
UCEC	KIR3DL1 →	+0.176	+2.103	<.001	<.001	3	2
UCEC	LSM3 →	+0.394	+2.119	.007	.003	3	2
UCEC	RAD51 →	+0.511	+2.010	.004	.005	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 967 associations by consensus.

Exploration

SUPT20HL2 survival (RNA) · tumor vs normal (RNA) · all SUPT20HL2 data types